GT Biopharma, Inc.

New Filing
CIK: 0000109657·Biotechnology·DELAWARE·Filed: Mar 7, 2025
Total Offering

$1,280,358

Amount Sold

$1,280,358

Investors

6

First Sale

Feb 25, 2025

Offering Details

Type
Equity, Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Michael Breen
Related Person
Alan Urban
Related Person
Bruce Wendel
Related Person
Rajesh Shrotriya
Related Person
Charles Casamento
Related Person

Company

GT Biopharma, Inc.

505 MONTGOMERY STREET

SAN FRANCISCO, CA, 94111

(800) 304-9888

SEC Filing

0000109657-25-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free